199 related articles for article (PubMed ID: 38323937)
1. Using blood transcriptome analysis for Alzheimer's disease diagnosis and patient stratification.
Zhong H; Zhou X; Uhm H; Jiang Y; Cao H; Chen Y; Mak TTW; Lo RMN; Wong BWY; Cheng EYL; Mok KY; Chan ALT; Kwok TCY; Mok VCT; Ip FCF; Hardy J; Fu AKY; Ip NY
Alzheimers Dement; 2024 Apr; 20(4):2469-2484. PubMed ID: 38323937
[TBL] [Abstract][Full Text] [Related]
2. [Identification of potential hub genes of Alzheimer's disease by weighted gene co-expression network analysis].
Xue J; Liu J; Geng M; Yue J; He H; Fan J
Nan Fang Yi Ke Da Xue Xue Bao; 2021 Dec; 41(12):1752-1762. PubMed ID: 35012905
[TBL] [Abstract][Full Text] [Related]
3. Integrated lipidomics and proteomics network analysis highlights lipid and immunity pathways associated with Alzheimer's disease.
Xu J; Bankov G; Kim M; Wretlind A; Lord J; Green R; Hodges A; Hye A; Aarsland D; Velayudhan L; Dobson RJB; Proitsi P; Legido-Quigley C;
Transl Neurodegener; 2020 Sep; 9(1):36. PubMed ID: 32951606
[TBL] [Abstract][Full Text] [Related]
4. Integrated Analysis of Weighted Gene Coexpression Network Analysis Identifying Six Genes as Novel Biomarkers for Alzheimer's Disease.
Zhang T; Liu N; Wei W; Zhang Z; Li H
Oxid Med Cell Longev; 2021; 2021():9918498. PubMed ID: 34367470
[TBL] [Abstract][Full Text] [Related]
5. Systematic analysis to identify transcriptome-wide dysregulation of Alzheimer's disease in genes and isoforms.
Fan C; Chen K; Zhou J; Wong PP; He D; Huang Y; Wang X; Ling T; Yang Y; Zhao H
Hum Genet; 2021 Apr; 140(4):609-623. PubMed ID: 33140241
[TBL] [Abstract][Full Text] [Related]
6. Condition-specific gene co-expression network mining identifies key pathways and regulators in the brain tissue of Alzheimer's disease patients.
Xiang S; Huang Z; Wang T; Han Z; Yu CY; Ni D; Huang K; Zhang J
BMC Med Genomics; 2018 Dec; 11(Suppl 6):115. PubMed ID: 30598117
[TBL] [Abstract][Full Text] [Related]
7. Application of Weighted Gene Co-Expression Network Analysis to Explore the Key Genes in Alzheimer's Disease.
Liang JW; Fang ZY; Huang Y; Liuyang ZY; Zhang XL; Wang JL; Wei H; Wang JZ; Wang XC; Zeng J; Liu R
J Alzheimers Dis; 2018; 65(4):1353-1364. PubMed ID: 30124448
[TBL] [Abstract][Full Text] [Related]
8. Identification of 5 Potential Predictive Biomarkers for Alzheimer's Disease by Integrating the Unified Test for Molecular Signatures and Weighted Gene Coexpression Network Analysis.
Zhou S; Ma G; Luo H; Shan S; Xiong J; Cheng G
J Gerontol A Biol Sci Med Sci; 2023 Mar; 78(4):653-658. PubMed ID: 36048437
[TBL] [Abstract][Full Text] [Related]
9. Identification of potential blood biomarkers for early diagnosis of Alzheimer's disease through RNA sequencing analysis.
Shigemizu D; Mori T; Akiyama S; Higaki S; Watanabe H; Sakurai T; Niida S; Ozaki K
Alzheimers Res Ther; 2020 Jul; 12(1):87. PubMed ID: 32677993
[TBL] [Abstract][Full Text] [Related]
10. Differentially expressed genes in Alzheimer's disease highlighting the roles of microglia genes including OLR1 and astrocyte gene CDK2AP1.
Li QS; De Muynck L
Brain Behav Immun Health; 2021 May; 13():100227. PubMed ID: 34589742
[TBL] [Abstract][Full Text] [Related]
11. Exploring Shared Pathogenesis of Alzheimer's Disease and Type 2 Diabetes Mellitus via Co-expression Networks Analysis.
Zhu Y; Ding X; She Z; Bai X; Nie Z; Wang F; Wang F; Geng X
Curr Alzheimer Res; 2020; 17(6):566-575. PubMed ID: 32781959
[TBL] [Abstract][Full Text] [Related]
12. Differential co-expression analysis reveals early stage transcriptomic decoupling in alzheimer's disease.
Upadhyaya Y; Xie L; Salama P; Cao S; Nho K; Saykin AJ; Yan J; Alzheimer's Disease Neuroimaging Initiative FT
BMC Med Genomics; 2020 Apr; 13(Suppl 5):53. PubMed ID: 32241275
[TBL] [Abstract][Full Text] [Related]
13. Alzheimer's disease heterogeneity explained by polygenic risk scores derived from brain transcriptomic profiles.
Chung J; Sahelijo N; Maruyama T; Hu J; Panitch R; Xia W; Mez J; Stein TD; ; Saykin AJ; Takeyama H; Farrer LA; Crane PK; Nho K; Jun GR
Alzheimers Dement; 2023 Nov; 19(11):5173-5184. PubMed ID: 37166019
[TBL] [Abstract][Full Text] [Related]
14. Genes related to neurotransmitter receptors as potential biomarkers for Alzheimer's disease.
Chen W; Zhang T; Zhang H
Neurosci Lett; 2024 May; 832():137816. PubMed ID: 38729598
[TBL] [Abstract][Full Text] [Related]
15. Visualizing modules of coordinated structural brain atrophy during the course of conversion to Alzheimer's disease by applying methodology from gene co-expression analysis.
Sato K; Mano T; Matsuda H; Senda M; Ihara R; Suzuki K; Arai H; Ishii K; Ito K; Ikeuchi T; Kuwano R; Toda T; Iwatsubo T; Iwata A;
Neuroimage Clin; 2019; 24():101957. PubMed ID: 31400633
[TBL] [Abstract][Full Text] [Related]
16. Cellular transcriptional alterations of peripheral blood in Alzheimer's disease.
Song L; Yang YT; Guo Q; ; Zhao XM
BMC Med; 2022 Aug; 20(1):266. PubMed ID: 36031604
[TBL] [Abstract][Full Text] [Related]
17. Integrated transcriptomics reveals the brain and blood biomarkers in Alzheimer's disease.
Yu H; Wang F; Wu JJ; Gong J; Bi S; Mao Y; Jia D; Chai GS
CNS Neurosci Ther; 2023 Dec; 29(12):3943-3951. PubMed ID: 37334737
[TBL] [Abstract][Full Text] [Related]
18. Identification of genes related to glucose metabolism and analysis of the immune characteristics in Alzheimer's disease.
Wang Y; Shen Z; Wu H; Yu Z; Wu X; Zhou L; Guo F
Brain Res; 2023 Nov; 1819():148545. PubMed ID: 37619853
[TBL] [Abstract][Full Text] [Related]
19. Intrinsic-overlapping co-expression module detection with application to Alzheimer's Disease.
Manners HN; Roy S; Kalita JK
Comput Biol Chem; 2018 Dec; 77():373-389. PubMed ID: 30466046
[TBL] [Abstract][Full Text] [Related]
20. Identification and validation of oxidative stress and immune-related hub genes in Alzheimer's disease through bioinformatics analysis.
Li S; Xiao J; Huang C; Sun J
Sci Rep; 2023 Jan; 13(1):657. PubMed ID: 36635346
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
